Aptamino

Aptamino is an early-stage biotech company developing computationally designed biologics. Its first focus is oral delivery of antibody drugs. Antibodies are among the most effective therapeutics available, but the digestive system breaks them down, so they have to be injected or infused. Aptamino uses generative protein design to engineer antibodies stable enough to survive the gut and reach the bloodstream, with the goal of making these drugs available as pills.